All India Institute Of Medical Sciences Tender

Work Description - Procurement Of Inj. Eculizumab 300mg

All India Institute of Medical Sciences (AIIMS), New Delhi, invites open tenders for the procurement of Inj. Eculizumab 300mg, as detailed in Tender Reference Number 36/H/Inj. Eculizumab 300mg/2025-26. This is a 'Buy' type contract, categorized under 'Goods,' specifically 'Drugs and Pharmaceutical Products'. Bidders must submit bids in two covers: the first containing scanned copies of the Earnest Money Deposit (EMD) and required documents as per Section VII, and the second containing the price bid as per the BOQ format. The EMD amount is fixed at ₹50,000, payable to AIIMS Main Grant, and can be submitted through BG/ST or EMD Exemption is allowed. The tender document can be downloaded from December 26th, 2025, 01:00 PM until January 16th, 2026, 01:00 PM. Bids must be submitted between December 26th, 2025, 01:00 PM and January 16th, 2026, 01:00 PM. The bid opening date is scheduled for January 17th, 2026, 01:00 PM, at the 1st floor, Main Hospital Store, AIIMS New Delhi. Offline payment methods are accepted, including Demand Draft, FDR, and Bank Guarantee. The successful bidder is expected to complete the work within 45 days, and the bid validity period is 270 days. There are no tender fees.